Veterinary Medicine & Animal HealthVeterinary Medicine & Animal Health

Are veterinary drugs regulated by the FDA?

Yes, veterinary drugs are strictly regulated by the U.S. Food and Drug Administration (FDA) through the Center for Veterinary Medicine (CVM). Under the Federal Food, Drug, and Cosmetic Act, the FDA ensures that animal medicines—including both therapeutic drugs and medicated feeds—are safe, effective, and properly manufactured.

Answer

The Food and Drug Administration (FDA) regulates animal medications under the same statutory framework used for human pharmaceuticals, establishing rigorous oversight to protect both animal health and human food safety. The regulation spans the entire product lifecycle, requiring formal approval of New Animal Drug Applications (NADAs) or Abbreviated New Animal Drug Applications (ANADAs) for generic versions before any therapeutic agent can legally enter the commercial market.

Operationally, the Center for Veterinary Medicine (CVM) enforces strict Current Good Manufacturing Practice (cGMP) regulations across all production lines. Pharmaceutical manufacturers and Contract Development and Manufacturing Organizations (CDMOs) producing veterinary health products must maintain robust Quality Assurance (QA) and Quality Control (QC) systems to ensure chemical stability, identity, strength, and purity.

This oversight is critical for international supply chains, contract manufacturing operations, and global animal health markets. For food-producing animals, the regulatory framework imposes precise tolerances and mandatory withdrawal periods to prevent harmful chemical residues from contaminating meat, milk, or eggs, thereby eliminating downstream food safety risks.

In clinical execution, these validated formulations are distributed through specialized animal health supply chains to veterinary hospitals, livestock operations, and research facilities. Compliance with these stringent validation protocols ensures product efficacy and mitigates legal liabilities for manufacturers, investors, and agricultural supply chain stakeholders.

Sandra Tashkovska Profile
Expert reviewed by Sandra Tashkovska, DVM

More questions on this topic